Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Dishman Carbogen Amcis Limited (DCAL.NS)

Compare
203.95
+16.09
+(8.56%)
At close: 3:30:03 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Arpit Janmejay Vyas Global MD & Director -- -- 1986
Ms. Deohooti Janmejay Vyas Whole Time Director 12M -- 1951
Mr. Harshil R. Dalal Global Chief Financial Officer -- -- --
Mr. Paolo Armanino Chief Operating Officer of Indian Operations -- -- --
Ms. Shrima Gaurangbhai Dave Compliance Officer & Company Secretary -- -- --
Mr. Dharmesh Desai GM of Secretarial & Legal -- -- --
Mr. Francois Baduel Vice President of Sales & Marketing -- -- --
Dieter Thuer Vice President of Human Resources -- -- --
Mr. Pascal Villemagne Chief Executive Officer of CARBOGEN AMCIS -- -- --
Dr. Himani S. Dhotre CEO of Projects & Operations -- -- --

Dishman Carbogen Amcis Limited

Dishman Corporate House
Iscon–Bopal Road Ambli
Ahmedabad, 380058
India
91 27 1742 0102 https://imdcal.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
1,132

Description

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Corporate Governance

Dishman Carbogen Amcis Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 28, 2025 at 10:59 AM UTC - June 2, 2025 at 12:00 PM UTC

Dishman Carbogen Amcis Limited Earnings Date

Recent Events

September 12, 2019 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers